Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-05

Clinical Trial Update: The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms

View source ↗

Summary

A Yale-sponsored clinical trial evaluating domperidone for refractory upper GI symptoms in gastroparesis is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Domperidone (domperidone)

Snippet

Sponsor: Yale University | Conditions: Gastroparesis | Status: NO_LONGER_AVAILABLE